← Insider Monitor
CervoMed Inc. logo
CRVO

CervoMed Inc.

Nasdaq · Pharmaceutical Preparations

2
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

CervoMed Inc. is a clinical-stage pharmaceutical company developing therapies for neurodegenerative diseases, including dementia with Lewy bodies and other age-related cognitive disorders.

Industry
Pharmaceutical Preparations
Headquarters
Boston, MA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
ALAM JOHN JCEO & PresidentBuy$117KNov 18, 2026
ALAM JOHN JCEO & PresidentBuy$36KNov 18, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for CRVO.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable CRVO activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.